Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

Gut

Volumn 39, Issue 1, 1996, Pages 5-8

  Van Der Burgh, A ^a   Dees, J ^a   Hop, W C J ^b   Van Blankenstein, M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Barrett's oesophagus; oesophageal cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; ENDOSCOPY; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029980994     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.1.5     Document Type: Article

References (19)

1. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87: 927-33.
2. Van der Veen AH, Dees J, Blankensteijn JD, van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989; 30: 14-8.
3. Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson T. Length of Barrett's oesophagus; an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-8.
4. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and authopsy findings. Gastroenterology 1990; 99: 818-22.
5. Visser O, Coebergh J, Schouten L, eds. Incidence of cancer in The Netherlands, 1991. Utrecht: Netherlands Cancer Registration, 1991.
6. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-9.
7. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991; 32: 1441-6.
8. Hameeteman W, Tytgat GNJ, Houthoff HJ, Van de Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-56.
9. Williamson WA, Ellis FH, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, et al. Barrett's oesophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151: 2212-6.
10. Sampliner RE, Mackel C, Fennerty MB, Garewal HS. Prospective incidence of cancer in Barrett's esophagus. Gastroenterology 1991; 100: A153.
11. Robertson CS, Mayberry JF, Nickelson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75: 760-3.
12. Sprung DJ, Ellis FH, Gibb SP. Incidence of adenocarcinoma in Barrett's esophagus [abstract]. Am J Gastroenterol 1984; 79: 817.
13. Sampliner RE, Kogan FJ, Morgan TR, Tripp M. Progression-regression of Barrett's esophagus [abstract]. Gastroenterology 1985; 88: 1567.
14. Mencke-Pluymers MBE, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) oesophagus. Cancer 1993; 72: 1155-8.
15. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's oesophagus. Am J Gastroenterol 1988; 83: 291-4.
16. Cameron AJ. Is the routine detection of CLE in a general population important? In: Giuli R, Tytgat GNJ, de Meester TR, eds. OESO. The oesophageal mucosa. 300 questions, 300 answers. Paris: 1993: 10-2.
17. Krishnadath KK, van Blankenstein M, Tilanus HW. Prognostic value of p53 in Barrett's oesophagus. Eur J Gastroenterol Hepatol 1994; 7: 81-4.
18. Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AF. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 1995; 175: 1-6.
19. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212-9.